Concepedia

Sharyle Fowler

SF

Statistics

Publications

26

Citations

953

H-Index

18

Active since

2003

Affiliations

University of Saskatchewan(Current)

Dalhousie University

University of Calgary

Harvard University

University of Manitoba

Sharyle Fowler is an author at University of Saskatchewan specializing in inflammatory bowel disease, medicine, and inflammation.

Publications per year

2003–2024

26

Publications

26

Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study

Silvio Danese, Jean‐Frédéric Colombel, Milan Lukáš et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +14

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · The Lancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study

Laurent Peyrin‐Biroulet, Jessica R. Allegretti, David T. Rubin et al. · Gastroenterology · 2023 · 92 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Effects of Cancer Treatment on Inflammatory Bowel Disease Remission and Reactivation

Jordan E. Axelrad, Sharyle Fowler, Sonia Friedman et al. · Clinical Gastroenterology and Hepatology · 2012 · 57 citations · Full text

Medicine, Immunology, Oncology +14

1–5 of 26